Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants
Neurocognitive Outcomes and Changes in Brain and Cerebral Spinal Fluid (CSF) Volume After Treatment of Post-Infectious Hydrocephalus (PIH) in Ugandan Infants by Shunting Versus ETV/CPC
1 other identifier
interventional
100
1 country
1
Brief Summary
Two treatment options exist for infant patients with hydrocephalus. Most patients are treated with a surgical procedure in which a shunt is inserted into the brain and abdomen. In recent years, however, another treatment has developed called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC).This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This study will evaluate patients in more detail to measure brain growth and development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started May 2013
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2013
CompletedFirst Submitted
Initial submission to the registry
July 29, 2013
CompletedFirst Posted
Study publicly available on registry
September 6, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 16, 2023
August 1, 2023
12.5 years
July 29, 2013
August 14, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change of Age-normed Bayley Scales of Infant Development (BSID)-III scores
Neurocognition will be measured using the BSID-III Cognitive Scale. Change will be assessed at 24 months post treatment from baseline score (12 months post treatment).
12 months and 24 months post treatment
Secondary Outcomes (3)
Brain Volume
12 months, 24 months, 5 years, and 7-10 years post treatment
CSF Volume
12 months, 24 months, 5 years, and 7-10 years post treatment
Vineland Adaptive Behavior Scales
5 years and 7-10 years post treatment
Study Arms (2)
Chhabra Shunt Placement
ACTIVE COMPARATORThe shunting arm will comprise a standard frontal approach ventriculoperitoneal shunt using a silastic Chhabra system.
ETV/CPC
ACTIVE COMPARATORThe Endoscopic Third Ventriculostomy/Choroid Plexus Cauterization (ETV/CPC) arm will comprise a standard frontal approach with flexible endoscopy.
Interventions
Eligibility Criteria
You may qualify if:
- Infants less than 180 days (six months) old
- Symptomatic hydrocephalus
- Post-infectious Hydrocephalus based on clinical and CT parameters2
- Must be from the following Ugandan districts: Bugiri, Busia, Iganga, Jinja, Kampala, Kamuli, Kapchorwa, Katakwi, Kumi, Mayuge, Mbale, Mukono, Pallisa, Sironko, Soroti, and Tororo
You may not qualify if:
- Any patient with a scalp erosion or infection that would exclude the patient from shunt implantation
- Any patient with ventricular loculations that would normally indicate the use of ventriculoscopy as an adjunct to shunt placement
- Any patient with absence of any visible cortical mantle on the CT
- Patients must be appropriate candidates for either surgical procedure - shunt placement alone or ETV/CPC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Children's Hospitallead
- Penn State Universitycollaborator
- The Hospital for Sick Childrencollaborator
- CURE Children's Hospital, Ugandacollaborator
Study Sites (1)
CURE Children's Hospital Uganda
Mbale, Uganda
Related Publications (3)
Harper JR, Cherukuri V, O'Reilly T, Yu M, Mbabazi-Kabachelor E, Mulando R, Sheth KN, Webb AG, Warf BC, Kulkarni AV, Monga V, Schiff SJ. Assessing the utility of low resolution brain imaging: treatment of infant hydrocephalus. Neuroimage Clin. 2021;32:102896. doi: 10.1016/j.nicl.2021.102896. Epub 2021 Nov 23.
PMID: 34911199DERIVEDPunchak M, Mbabazi Kabachelor E, Ogwal M, Nalule E, Nalwoga J, Ssenyonga P, Mugamba J, Rattani A, Dewan MC, Kulkarni AV, Schiff SJ, Warf B. The Incidence of Postoperative Seizures Following Treatment of Postinfectious Hydrocephalus in Ugandan Infants: A Post Hoc Comparison of Endoscopic Treatment vs Shunt Placement in a Randomized Controlled Trial. Neurosurgery. 2019 Oct 1;85(4):E714-E721. doi: 10.1093/neuros/nyz122.
PMID: 31086941DERIVEDKulkarni AV, Schiff SJ, Mbabazi-Kabachelor E, Mugamba J, Ssenyonga P, Donnelly R, Levenbach J, Monga V, Peterson M, MacDonald M, Cherukuri V, Warf BC. Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda. N Engl J Med. 2017 Dec 21;377(25):2456-2464. doi: 10.1056/NEJMoa1707568.
PMID: 29262276DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benjamin C Warf, MD
Boston Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Neurosurgery, Hydrocephalus and Spina Bifida Chair
Study Record Dates
First Submitted
July 29, 2013
First Posted
September 6, 2013
Study Start
May 27, 2013
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
August 16, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared with researchers outside of the study team.